Search Results 1441-1450 of 16074 for jhajjarcancer
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
Treatment with panitumumab may interfere with the ability of tumor cells to grow and spread. Some tumors need growth factors to keep growing. Growth factor ...
Mayo Clinic Compass brings insight into Kansas Heart Hospital's patient safety, experience, and surgical outcomes scores.
PURPOSE: This randomized phase III trial studies how well an accelerated course of higher per daily radiation therapy with concomitant boost works compared to ...
The purpose of this study is to test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies.
This phase II trial studies how well olaparib and cediranib maleate work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Research in the Mayo Clinic Department of Otolaryngology — Head and Neck Surgery combines form and function to advance facial plastic surgery and ...
Biological therapies, such as lenalidomide and anakinra, may stimulate or suppress the immune system in different ways and stop cancer cells from growing. Drugs ...
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.